To include your compound in the COVID-19 Resource Center, submit it here.

Immuno-Designed, Epimmune cancer deal

Immuno-Designed (Paris, France) and EPMN partnered to evaluate

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE